EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: person:"Bayoumi, Ahmed M."
Narrow search

Narrow search

Year of publication
Subject
All
Antiretrovirals 1 Cost analysis 1 Cost-benefit 1 Drug policy 1 HIV infections 1 Patient compliance 1 Pharmacoeconomics 1 Qualitative research 1 Resources allocation 1 Transparency 1 Willingness-to-pay 1
more ... less ...
Online availability
All
Undetermined 3
Type of publication
All
Article 3
Language
All
Undetermined 3
Author
All
Bayoumi, Ahmed M. 3 Lin-in Tseng, Alice 1 Oh, Paul 1 Risebrough, Nancy 1 Rosenberg-Yunger, Zahava R.S. 1 Scalera, Alissa 1 Shear, Neil 1
more ... less ...
Published in...
All
Disease Management and Health Outcomes 1 Health Policy 1 PharmacoEconomics 1
Source
All
RePEc 3
Showing 1 - 3 of 3
Cover Image
Transparency in Canadian public drug advisory committees
Rosenberg-Yunger, Zahava R.S.; Bayoumi, Ahmed M. - In: Health Policy 118 (2014) 2, pp. 255-263
Transparency in health care resource allocation decisions is a criterion of a fair process. We used qualitative methods to explore transparency across 11 Canadian drug advisory committees.
Persistent link: https://www.econbiz.de/10011116915
Saved in:
Cover Image
The Measurement of Contingent Valuation for Health Economics
Bayoumi, Ahmed M. - In: PharmacoEconomics 22 (2004) 11, pp. 691-700
In health economics, contingent valuation is a method that elicits an individual Contingent valuation questions can be targeted to any of the following groups: the general population, to value health insurance premiums for programmes; users of a health programme, to value the associated...
Persistent link: https://www.econbiz.de/10005243144
Saved in:
Cover Image
Clinical and Economic Implications of Non-Adherence to HAART in HIV Infection
Scalera, Alissa; Bayoumi, Ahmed M.; Oh, Paul; … - In: Disease Management and Health Outcomes 10 (2002) 2, pp. 85-91
Highly active antiretroviral therapy (HAART) has dramatically altered the natural history of HIV disease. Studies demonstrate that =95% adherence is necessary to garner the full benefits of HAART. However, appropriate adherence to treatment is difficult and challenging. This paper provides an...
Persistent link: https://www.econbiz.de/10005448835
Saved in:
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...